A Study of SKB315 in Patients With Advanced Solid Tumors

NCT05367635 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SKB315 for injection
DRUG: Drug: Tagitanlimab Drug: Capecitabine

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.